EUVIMEDEUVIMED entdecken
Crossref

Pharmacokinetics of a Novel Trioxane Antimalarial Drug 99/411: Alterations Upon Rifampicin Coadministration, Single and Multiple Oral Dose Drug–Drug Interactions in Sprague-Dawley Rats

Mahendra Kumar Hidau, Yeshwant Singh, Shio Kumar Singh

International Journal of Pharmacokinetics · 2017

DOI: 10.4155/ipk-2017-0001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Pharmacokinetics, 2017. Verfasst von Mahendra Kumar Hidau und 2 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben. Gefördert von: CSIR-CDRI, Council for Scientific and Industrial Research.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • CSIR-CDRI
  • Council for Scientific and Industrial Research

Zitieren

APA

Hidau, M. K., Singh, Y., & Singh, S. K. (2017). Pharmacokinetics of a Novel Trioxane Antimalarial Drug 99/411: Alterations Upon Rifampicin Coadministration, Single and Multiple Oral Dose Drug–Drug Interactions in Sprague-Dawley Rats. International Journal of Pharmacokinetics. https://doi.org/10.4155/ipk-2017-0001

Vancouver

Hidau MK, Singh Y, Singh SK. Pharmacokinetics of a Novel Trioxane Antimalarial Drug 99/411: Alterations Upon Rifampicin Coadministration, Single and Multiple Oral Dose Drug–Drug Interactions in Sprague-Dawley Rats. International Journal of Pharmacokinetics. 2017. doi:10.4155/ipk-2017-0001

BibTeX
@article{Hidau2017,
  author = {Hidau, Mahendra Kumar and Singh, Yeshwant and Singh, Shio Kumar},
  title = {Pharmacokinetics of a Novel Trioxane Antimalarial Drug 99/411: Alterations Upon Rifampicin Coadministration, Single and Multiple Oral Dose Drug–Drug Interactions in Sprague-Dawley Rats},
  journal = {International Journal of Pharmacokinetics},
  year = {2017},
  doi = {10.4155/ipk-2017-0001}
}
Kostenlos starten →